Clinical Trial Update: Evaluation of the Efficacy of an inTerdialytic "Ethanol 40% v/v - enoxapaRin 1000 U/mL" Lock solutioN to Prevent Tunnelled Catheter Infections in Chronic Hemodialysis Patients [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating an ethanol-enoxaparin lock solution to prevent tunneled catheter infections in chronic hemodialysis patients is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tunnelled Hemodialysis Catheter Infection

Drugs mentioned

• Ethanol 40% v/v - enoxaparin 1000 U/mL lock solution

Snippet

Sponsor: University Hospital, Clermont-Ferrand | Conditions: Tunnelled Hemodialysis Catheter Infection | Phase 3 | Status: RECRUITING